Frederic Desdouits

Frederic joined Seqens in October 2017 as Uetikon CEO (German CDMO). He was appointed Managing Director of Seqens CDMO in April 2018 and became a member of the Executive Committee group. Previously, Frederic spent six years with Pierre Fabre Group as Executive Vice President for Corporate Licensing, Acquisition and Market Intelligence and as Director of Pharmaceuticals U.S. Frederic received an engineering degree from Ecole Polytechnique (France), a PhD in neurosciences and is a Certified Financial Analyst.